These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10971746)

  • 1. Insulin-like growth factor (IGF)-I affects parasite growth and host cell migration in experimental cutaneous leishmaniasis.
    Gomes CM; Goto H; Ribeiro Da Matta VL; Laurenti MD; Gidlund M; Corbett CE
    Int J Exp Pathol; 2000 Aug; 81(4):249-55. PubMed ID: 10971746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor I is a growth-promoting factor for Leishmania promastigotes and amastigotes.
    Goto H; Gomes CM; Corbett CE; Monteiro HP; Gidlund M
    Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13211-6. PubMed ID: 9789067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of insulin-like growth factor-I on Leishmania amazonensis promastigote arginase activation and reciprocal inhibition of NOS2 pathway in macrophage in vitro.
    Vendrame CM; Carvalho MD; Rios FJ; Manuli ER; Petitto-Assis F; Goto H
    Scand J Immunol; 2007; 66(2-3):287-96. PubMed ID: 17635806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual Role of Insulin-Like Growth Factor (IGF)-I in American Tegumentary Leishmaniasis.
    de O Mendes-Aguiar C; Lopes-Siqueira C; Pettito-Assis F; Pereira-Oliveira M; de Oliveira-Neto MP; Pirmez C; Da-Cruz AM; Goto H
    J Immunol Res; 2021; 2021():6657785. PubMed ID: 33860062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic Effect of Hormone Insulin-Like Growth Factor-I in Immune Response and Pathogenesis in Leishmaniases.
    Reis LC; Ramos-Sanchez EM; Araujo FN; Leal AF; Ozaki CY; Sevillano OR; Uscata BA; Goto H
    J Immunol Res; 2021; 2021():6614475. PubMed ID: 34036108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmania amazonensis: Increase in ecto-ATPase activity and parasite burden of vinblastine-resistant protozoa.
    Giarola NL; Silveira TS; Inacio JD; Vieira LP; Almeida-Amaral EE; Meyer-Fernandes JR
    Exp Parasitol; 2014 Nov; 146():25-33. PubMed ID: 25176449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo activity of a palladacycle complex on Leishmania (Leishmania) amazonensis.
    Paladi Cde S; Pimentel IA; Katz S; Cunha RL; Judice WA; Caires AC; Barbiéri CL
    PLoS Negl Trop Dis; 2012; 6(5):e1626. PubMed ID: 22616018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-I serum levels and their biological effects on Leishmania isolates from different clinical forms of American tegumentary leishmaniasis.
    de Souza LD; Vendrame CM; de Jesus AR; Carvalho MD; Magalhães AS; Schriefer A; Guimarães LH; Carvalho EM; Goto H
    Parasit Vectors; 2016 Jun; 9(1):335. PubMed ID: 27286813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontline Science:
    Hurrell BP; Beaumann M; Heyde S; Regli IB; Müller AJ; Tacchini-Cottier F
    J Leukoc Biol; 2017 Nov; 102(5):1187-1198. PubMed ID: 28798144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
    Halliday A; Bates PA; Chance ML; Taylor MJ
    Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophils have a protective role during early stages of Leishmania amazonensis infection in BALB/c mice.
    Sousa LM; Carneiro MB; Resende ME; Martins LS; Dos Santos LM; Vaz LG; Mello PS; Mosser DM; Oliveira MA; Vieira LQ
    Parasite Immunol; 2014 Jan; 36(1):13-31. PubMed ID: 24102495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis.
    Mendonça DV; Lage LM; Lage DP; Chávez-Fumagalli MA; Ludolf F; Roatt BM; Menezes-Souza D; Faraco AA; Castilho RO; Tavares CA; Barichello JM; Duarte MC; Coelho EA
    Exp Parasitol; 2016 Oct; 169():34-42. PubMed ID: 27427166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Sequestration of Leishmania mexicana by Neutrophils Contributes to the Development of Chronic Lesion.
    Hurrell BP; Schuster S; Grün E; Coutaz M; Williams RA; Held W; Malissen B; Malissen M; Yousefi S; Simon HU; Müller AJ; Tacchini-Cottier F
    PLoS Pathog; 2015 May; 11(5):e1004929. PubMed ID: 26020515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of pentoxifylline on experimental cutaneous leishmaniasis due to Leishmania (Leishmania) amazonensis.
    de Sá Oliveira T; Capp Neto M; Martins BJ; Rodrigues HA; Antonino RM; Magalhães AV
    Mem Inst Oswaldo Cruz; 2000; 95(4):477-82. PubMed ID: 10904402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of nanoemulsion with Pterodon emarginatus Vogel oleoresin for topical treatment of cutaneous leishmaniasis.
    Kawakami MYM; Zamora LO; Araújo RS; Fernandes CP; Ricotta TQN; de Oliveira LG; Queiroz-Junior CM; Fernandes AP; da Conceição EC; Ferreira LAM; Barros ALB; Aguiar MG; Oliveira AEMFM
    Biomed Pharmacother; 2021 Feb; 134():111109. PubMed ID: 33341050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An 8-hydroxyquinoline-containing polymeric micelle system is effective for the treatment of murine tegumentary leishmaniasis.
    Lage LM; Barichello JM; Lage DP; Mendonça DV; Carvalho AM; Rodrigues MR; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Coelho EA; Duarte MC
    Parasitol Res; 2016 Nov; 115(11):4083-4095. PubMed ID: 27365053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of polymorphonuclear leukocytes in the resistance to cutaneous Leishmaniasis.
    Lima GM; Vallochi AL; Silva UR; Bevilacqua EM; Kiffer MM; Abrahamsohn IA
    Immunol Lett; 1998 Dec; 64(2-3):145-51. PubMed ID: 9870666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania proteophosphoglycans regurgitated from infected sand flies accelerate dermal wound repair and exacerbate leishmaniasis via insulin-like growth factor 1-dependent signalling.
    Giraud E; Lestinova T; Derrick T; Martin O; Dillon RJ; Volf P; Műller I; Bates PA; Rogers ME
    PLoS Pathog; 2018 Jan; 14(1):e1006794. PubMed ID: 29352310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo near-infrared fluorescence imaging of Leishmania amazonensis expressing infrared fluorescence protein (iRFP) for real-time monitoring of cutaneous leishmaniasis in mice.
    Oliveira JC; da Silva AC; Oliveira RA; Pereira VR; Gil LH
    J Microbiol Methods; 2016 Nov; 130():189-195. PubMed ID: 27498229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.